Treatment of autoimmune diseases with intravenous gammaglobulin.
Gelfand
E W
EW
Department of Pediatrics, National Jewish Center for Immunology and Respiratory Medicine, Denver, CO 80206.
D000361:Agammaglobulinemia / Q000276:immunology / Q000628:therapy; D001327:Autoimmune Diseases / Q000276:immunology / Q000628:therapy*; D015551:Autoimmunity; D000949:Histocompatibility Antigens Class II / Q000276:immunology; D006801:Humans; D007108:Immune Tolerance; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007249:Inflammation / Q000628:therapy; D008954:Models, Biological; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000276:immunology; D016176:T-Lymphocyte Subsets / Q000276:immunology
D000949:Histocompatibility Antigens Class II; D016756:Immunoglobulins, Intravenous; D016693:Receptors, Antigen, T-Cell, alpha-beta